31 sels), of which ten vessels (10/38, 26.31%) had occluded before coming to our hospital. Three patients (3/19, 15.78%) had a history of hypertension, five had a history of smoking. The mean age of these 19 patients was 33 yrs (24 ~ 42 yrs), with a slight male preponderance (males/females = 13/6). Initial clinical presentations were TIAs (14/19, 73.68%) and minor stroke (5/19, 26.32%), symptoms attacked alternatively for five patients (5/38, 13.16%). Seven vessels (7/28, 25%) occluded within one to three years, of which three occluded asymptomatically, four acutely occluded vessels accompanied acute stroke. Nine vessels (9/28, 32.14%) were treated by conservative antiplatelet agents and one treated by bypass surgery had related recurrent TIAs. Vessels treated by angioplasty (balloon or stent) remained patent and free of symptoms.
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The stenosed bilateral MCA may occlude within one to three years without intervention. The pathogenesis of this special disease is unclear, it may be genetic or due to asymptomatic infection.
The results showed that earlier appropriate treatment can resolve the clinical symptoms and somehow change the natural history of this disease. Conservative medical therapy cannot prevent further stroke attack. Collaterals are very important for these special patients.
Summary
To assess the natural history, pathogenesis, and treatment modalities of symptomatic bilateral middle cerebral artery stenosis, we retrospectively evaluated a consecutive series of patients for their medical history, anamnesis, and our treatment protocol.
Treatment included transluminal angioplasty, bypass surgery and/or conservative antiplatelet therapy for prevention of the stroke attack and vessel reconstruction. Indications, feasibility, effectiveness, and complications of treatment are also discussed.
A series of 19 patients with symptomatic bilateral middle cerebral artery (MCA) stenosis were treated consecutively from 1998 to 2002. Medical history, anamnesis, and treatment protocol were reviewed and evaluated retrospectively, Of these 19 patients, six (six vessels, 31.57%) were treated by balloon (two vessels) or stent-assistant angioplasty (four vessels), four (four vessels, 21.05%) were treated by bypass surgery, 18 vessels plus ten vessels occluded before treatment (47.37%) were conservatively treated by antiplatelet agents. 24 vessels (12 patients) were followed from three months to four years by angiography (nine cases), TCD (12 cases), or MRA (five cases).
A total of 38 vessels were involved (19 ves- Figure 1 Case 1, a 34-year-old man presented with recurrent weakness of his left arm, acute CT showed no abnormality, cerebral angiography showed bilateral MCA stenosis at the M1 segment(A,B). Symptoms improved after anticoagulation and antiplatelet therapy. Three years later, the young man complained of aphasia and weakness of his right arm for 48 hours, MRI showed a small infarction lesion in the left internal capsular (C). Acute angiography showed his right MCA was completely occluded and the left M1 segment was acutely thrombosed (D,E). Superselective thrombolysis was given in the left MCA (F), after 300000 IU urokinase infused, the M1 segment was recanalized but there was stenosis located at the thrombolysis position (G). Acute angioplasty was decided, the patient changed to general anesthesia, a 6 F guiding catheter (Envoy, Cordis Co.) was navigated to the left petrosal segment. A coronary stent (AVE, Medtronic) was deployed at the stenosed segment with
Introduction
The natural history of intracranial artery stenosis has been reported in the literature [1] [2] [3] . In African American, Chinese, and Japanese patients, the incidence of intracranial disease is greater than that of extracranial disease, and thus represents a major source of ischemic stroke 2, 12, 13, 15, 16 . Heyden et Al 18 reported that intracranial stenoses tend to affect younger patients more often than extracranial stenoses, possibly resulting in a higher cumulative risk of stroke. Material on bilateral MCA stenosis has not been reported to date. Both the natural history and pathogenesis of MCA stenosis are unclear as most of these patients have no evidence of arteriosclerosis, or relative dangerous history of diabetes, hypertension etc. Patients are younger than those with arteriosclerosis intracranial artery stenosis. Clinical presentations mainly are TIAs or minor stroke, one side or both sides alternatively, some of the patients being asymptomatic for a long time after the initial attack with or without medical therapy, but most of them had recurrent attacks. Some-times it is difficult for doctors to decide which therapeutic method to use. So we reviewed the clinical, follow-up and treatment protocols of these 19 patients treated consecutively in our department, to give us some clue as to natural history and selection of treatment methods.
Patients and Methods
A retrospective analysis was conducted of patients with symptomatic MCA stenoses treated between 1998 and 2002. In all 19 cases were received and treated consecutively at our hospital. Eleven patients consulted a neurologist first and eight consulted neurosurgeons. Primary symptoms are summarised in table 1. All the patients were evaluated for their clinical history, family history and anamnesis (table 2). They were given expectant treatment (antiplatelet antifibrinolytic) and related physical examination including CT/MRI, TCD, ultrasonography. Cerebral perfusion was evaluated by SPECT with xenon-133. Cerebral angiography was done after hospital admission. J K L Figure 2 Case 2, a 32-year-old man complained of intermittent weakness of his right arm, acute MRI showed no abnormality, angiogram showed bilateral MCA stenosis at the M1 segment (A,B). Balloon angioplasty was decided, the patient accepted general anesthesia, transfemoral route was selected, a 8 F guiding catheter was inserted at both ICA respectively, a 2.5 x 8 mm balloon (Magellan, Balt Co.) with the support of 0.014 in microwire was navigated to both stenosed sites, the balloon was gently dilated with the 10 ml syringe by hand. The manipulation was repeated twice respectively. A satisfactory result was obtained at the right side (C,E), but local stenosis remained on the left (D,F); procedure was stopped for fear of vessel rupture. After the procedure, the patient was given antiplatelet therapy (aspirin, 80 mg per day), the patient clinically recovered.
His four year angiogram showed good patency of the right side (G); on the left side, a slight stenosis was better than four years ago, but there were more collaterals from the ipsilateral ACA (E). It was interesting to find that there were more dilated small vessels at the stenosed left M1 segment like a "Moya moya phenomenon". The patient remained symptom-free. Stenoses and collaterals were evaluated. Primary treatment modalities are summarised in table 3. Of our 19 patients, six (six vessels, 31.57%) were treated by balloon (two vessels, figure 2) or stent-assisted angioplasty (four vessels, figure 1 ). Four cases (four vessels) were treated by bypass surgery (STA-MCA anastomosis). Indications and protocols for angioplasty: 1) Recurrent TIAs or minor stroke attack and/or refractory to medical treatment;
2) Collaterals are not enough to maintain the normal blood perfusion, SPECT showed low perfusion.
3) The structure of stenosed vessels belonged to Mori's A type 10 . 4) Acute occlusion. 5) TCD showed the velocity > 250 cm/s at the stenosed segment and < 50 cm/s at distal M1 segment, pulsatility index (PI) < 0.55.
18 vessels plus ten vessels occluded before treatment (47.37%) were conservatively treated only by antiplatelet method. 24 vessels (12 patients) were followed from three months to four years by angiography (nine cases), TCD (12 cases), or MRA (five cases).
Results
A total of 38 stenosed vessels (19 cases) were involved, of which ten vessels (10/38, 26.31%) had occluded before coming to our hospital. Three of the patients (3/19, 15.78%) had a history of hypertension, five had a history of smoking. None had a family history. The mean age of these 19 patients was 33 yrs (24-42 yrs) and there was a slight male preponderance (males/females = 13/6). Primary clinical presentations were TIAs (14/19, 73.68%) and minor stroke (5/19, 26.32%), symptoms attacked alternatively for five patients (5/38, 13.16%).
Ipsilateral low-perfusion was discovered in ten patients by SPECT, of which two cases showed bilateral low-perfusion. Six patients showed normal perfusion, of which six patients were concomitant with the angiography results, which had enough collaterals from ASA and PCA.
Ten patients (ten related vessels, 35.71%) had recurrent TIAs within the three months to four years follow-up period; of these cases, nine vessels (9/28, 32.14%) were treated with conservative antiplatelet methods. One vessel was treated by bypass surgery three months after intervention. Seven vessels (7/28, 25%) occluded within one to three years, of these occluded vessels three occluded asymptomatically, four acutely occluded vessels were accompanied by acute stroke. Vessels treated by angioplasty (balloon or stent) remained open and free of symptoms at the follow-up period (one to four years).
Discussion
Symptomatic bilateral MCA stenosis always occurred in young people. In our series of patients, lesions involves the bilateral M1 segment, other intracranial arteries were normal and the pathogenesis is unclear. Most of them have no conventional dangerous pathogenic reasons for intracranial artery stenosis such as hypertension, diabetes, atherosclerosis, etc. Inflammation, genetic predisposition and immunity may be attributed to the mechanism. Initial clinical presentations of bilateral MCA Ischemic stroke can be caused by intracranial atherosclerotic stenosis with resulting chronic hypoperfusion, emboli, or total occlusion. The estimated risk of stroke in the setting of intracranial stenosis varies from approximately 7 to 40% per year with or without medical therapy. Data concerning stenosis of the MCA indicate a stroke risk of at least 8% per year. Caplan et Al reported that patients with MCA disease were younger. Our results showed 38% TIAs were caused by intracranial artery stenosis (in press). The purpose of treatment for bilateral MCA stenosis is to resolve the clinical symptoms by reconstructing of stenosed vessel and increasing the hemispheric blood perfusion, A retrospective, multicenter study 2 has reported clinical outcomes of symptomatic patients with angiographically defined stenosis of 50% to 99% in intracranial and ischemic events involving the territory of the stenotic vessel. Over a median follow-up of 19.3 months in patients treated with aspirin, 24% had a stroke, and 17% had myocardial infarction or sudden death. In this study, patients treated with warfarin had fewer ischemic strokes and myocardial infarctions but more in-tracerebral haemorrhages. In the medically managed arm of a trial of EC/IC bypass surgery 3 36% of patients with high-grade distal ICA stenosis and 24% of patients with MCA stenosis treated with aspirin had stroke (overall average follow-up for study was 55.8 months). In our series, patients were commonly medicated with antiplatelet drugs when hospitalized. Those who accepted endovascular therapy continued antiplatelet therapy for three months.
Intraluminal balloon angioplasty may be dangerous, sometimes causing fatal complications 5, [6] [7] [8] [9] [10] . But with the new generation of flexible coronary stents and skilled endovascular techniques, stent-assisted angioplasty seemed relatively feasible and safe for symptomatic atherosclerosis in intracranial arteries, but for bilateral MCA stenosis it is very special because the pathogenetic mechanisms are still unclear. Some think that angioplasty must be used with caution because we do not know about the natural history of this disease. We tried the method deliberately by balloon angioplasty for our early two cases and four cases with stentassisted angioplasty. We obtained favorable results with six vessels dilated successfully. The longer follow-up (eight months to three years) also proved effective in preventing the stroke attack. Despite our success, we think good indications must be emphasized. According to our experience, the indications for angioplasty are: 1) recurrent TIAs or minor stroke attack and/or refractory to medical treatment;
2) collaterals are not enough to maintain the normal blood perfusion;
3) structure of the stenosed vessel belongs to Mori's A type 10 ; 4) acute occlusion. Early reconstruction by angioplasty may prevent this deterioration process, but it need further observation, the longest follow-up in our series is four years (case 2): serial angiogram/MRA showed that the angioplasted vessel wall becomes more and more regular and smooth. Chronic occlusion may be asymptomatic, but acute occlusion will lead to obvious clinical symptoms, as in our case 1.
Indications for bypass surgery are those patients who are not only refractory to conservative medical treatment, but dangerous for endovascular treatment. The purpose of antiplatelet therapy is to prevent platelet aggregation in the atherosclerotic artery, but most of the cases with bilateral middle cerebral artery stenosis had no evidence of atherosclerosis. In fact, during the follow-up period, eight patients (eight related vessels, 21.05%) had recurrent TIAs within the three months to four years follow-up period, of which seven vessels were treated with conservatively antiplatelet methods, one vessel was treated by bypass surgery three months after the procedure. This may indicate that medical therapy alone cannot change the natural deteriorated process and prevent stroke attack.
